# Autologous Bone Marrow Mononuclear Stem Cell for Children Suffering From Liver Cirrhosis Due to Biliary Atresia

> **NCT03468699** · PHASE2 · COMPLETED · sponsor: **Vinmec Research Institute of Stem Cell and Gene Technology** · enrollment: 17 (actual)

## Conditions studied

- Liver Cirrhosis, Biliary

## Interventions

- **COMBINATION_PRODUCT:** Autologous BMMC transplantation

## Key facts

- **NCT ID:** NCT03468699
- **Lead sponsor:** Vinmec Research Institute of Stem Cell and Gene Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-02
- **Primary completion:** 2021-09-30
- **Final completion:** 2021-10-31
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2024-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03468699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03468699, "Autologous Bone Marrow Mononuclear Stem Cell for Children Suffering From Liver Cirrhosis Due to Biliary Atresia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03468699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*